Reliability of amitriptyline dose prediction based on single-dose plasma levels

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Psychiatry

Background:

• Therapeutic drug monitoring is crucial for optimizing antidepressant efficacy.
• Tricyclic antidepressants (TCAs) require careful dosage adjustments.
• Predicting steady-state TCA levels from single doses can improve treatment initiation.

Purpose of the Study:

• To prospectively evaluate the predictability of therapeutic tricyclic antidepressant (TCA) dosage based on single-dose concentrations.
• To assess the reliability of using 18- and 24-hour single-dose TCA levels to predict steady-state concentrations.
• To determine the clinical utility of rapid dose institution based on these predictions.

Main Methods:

• Prospective study involving 30 subjects receiving amitriptyline.
• Assessed predictive capacity of 18- and 24-hour single-dose TCA levels against steady-state levels in 11 subjects.
• Predicted and instituted doses to achieve a target steady-state concentration of 200 ng/ml in 19 subjects based on 18-hour levels.

Main Results:

• Dose prediction based on single-dose TCA levels was reliable.
• Achieved a mean steady-state TCA level of 204 ng/ml.
• Approximately 90% of subjects achieved therapeutic TCA levels, with 84% showing clinical improvement within 2 weeks.

Conclusions:

• Single-dose TCA level prediction is a reliable method for determining therapeutic dosage.
• This approach facilitates rapid achievement of therapeutic TCA concentrations.
• The findings support the clinical usefulness of TCA dose prediction for improved patient outcomes.